API
< Back to all clusters
[BUSINESS] · United States · 2 sources

started · updated

vVardis raises $175 million ahead of NYSE IPO

Dental health firm vVardis has raised $175 million in preparation for its listing on the New York Stock Exchange under the ticker symbol VVVV. The company priced 9.72 million shares at $18 per share.

vVardis specializes in providing the first commercially available peptide-containing formulation designed to treat early cavities without the need for drilling. Co-founders and Co-CEOs Dr. Haley Abivardi and Dr. Goly Abivardi are scheduled to discuss the company’s transition to a public entity on NYSE Live.

Entities

Dr. Goly Abivardi · Dr. Haley Abivardi · New York Stock Exchange · vVardis